MedTrace Logo

Improve Acute Reperfusion Treatment Quality for Stroke in China, IMPROVE: Stroke Care in China

NCT03578107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15895

Last updated 2021-11-02

No results posted yet for this study

Summary

In order to bridge the great gaps, Chinese Stroke Association (CSA) and American Heart Association (AHA) sought to develop, conduct, and assess a multifaceted quality improvement intervention to increase the adherent rate of IV tPA and ET and improve 3-month clinical outcomes for these patients through our cluster-randomized stepped-wedge IMPROVE: Stroke in China trial.

Conditions

Interventions

BEHAVIORAL

improvement of quality of stroke care

1. hospital tool kits for quality improvement of reperfusion therapy ; 2. organizational stakeholder and opinion leader meetings; 3. data monitoring and feedback reports； 4. webinar for hospital teams

Sponsors & Collaborators

Principal Investigators

  • Yongjun Wang, MD · Beijing Tiantan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2020-07-31
Completion
2020-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03578107 on ClinicalTrials.gov